Online citations, reference lists, and bibliographies.
← Back to Search

Liquid Formulation Containing Doxorubicin-loaded Lipid-core Nanocapsules: Cytotoxicity In Human Breast Cancer Cell Line And In Vitro Uptake Mechanism.

Michelli B. Antonow, Ana Carolina C. Asbahr, P. Raddatz, A. Beckenkamp, A. Buffon, Sílvia S. Guterres, Adriana R. Pohlmann
Published 2017 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Cancer is a major public health problem in the world, being breast cancer the most frequent cancer affecting women. Despite advances in detection and treatment, mortality rates remain high. Therefore, new approaches for breast cancer treatments are necessary. In this study, our objective was to develop a liquid formulation containing doxorubicin-loaded lipid-core nanocapsules (DOX-LNC), to evaluate the in vitro antiproliferative activity and to determine the nanocapsules uptake by MCF-7 cells. Lipid-core nanocapsules (LNC), blank formulation, and DOX-LNC, proposed treatment, were prepared by self-assembling using the solvent displacement method. Hydrodynamic mean diameters (z-average) were respectively 191±31nm and 230±23nm presenting narrow size distributions. Drug content was 0.102±0.029mgmL-1 with an encapsulation efficiency higher than 90%. Formulations were applied to semiconfluent MCF-7 cells. After 24h, LNC showed no cytotoxicity, while DOX-LNC showed an IC50 of 4.49 micromolar. After 72h of incubation, DOX-LNC showed an IC50 of 1.60 micromolar demonstrating a sustained effect. The nanocapsules were internalized by endocytosis mediated by caveolin and by fluid phase endocytosis, which are active transport mechanisms. In conclusion, the liquid formulation containing DOX-LNC showed to be a promising product for the breast cancer treatment opening new avenues for further in vivo studies.
This paper references
10.1002/mabi.201500043
Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles.
J. Wang (2015)
10.1515/9783050077338-026
Y
E. M. S. J. xviii (1824)
10.3322/caac.21332
Cancer statistics, 2016
Rebecca L. Siegel Mph (2016)
10.1515/9783111413426-013
L
Il Liceo (1824)
10.1155/2013/456409
Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review
J. Lao (2013)
10.1016/S1470-2045(06)70793-8
Emerging use of nanoparticles in diagnosis and treatment of breast cancer.
M. Yezhelyev (2006)
10.3322/caac.21332
Cancer statistics, 2016
R. Siegel (2016)
10.1007/s11095-016-1958-5
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Daniel Bobo (2016)
10.1007/s11095-010-0073-2
Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates
V. Filipe (2010)
10.1515/9783111576855-009
D
Saskia Bonjour (1824)
10.1166/JBN.2016.2215
Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.
S. F. Rodrigues (2016)
Elevated expression of caveolin is associated with prostate and breast cancer.
G. Yang (1998)
10.1016/J.COLSURFA.2013.04.015
Variable temperature multiple light scattering analysis to determine the enthalpic term of a reversible agglomeration in submicrometric colloidal formulations: A quick quantitative comparison of the relative physical stability
L. Fiel (2013)
10.1517/17425247.2013.769956
Poly(ϵ-caprolactone) microcapsules and nanocapsules in drug delivery
A. Pohlmann (2013)
10.1016/j.ijpharm.2014.12.035
Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
Mona Alibolandi (2015)
10.2147/IJN.S74378
Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles
L. Cabeza (2015)
10.2147/IJN.S84909
Caenorhabditis elegans as an alternative in vivo model to determine oral uptake, nanotoxicity, and efficacy of melatonin-loaded lipid-core nanocapsules on paraquat damage
M. Charão (2015)
10.2174/138161211796904812
Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol.
G. C. Pereira (2011)
10.2174/092986709788803312
Doxorubicin: the good, the bad and the ugly effect.
C. Carvalho (2009)
10.1016/S0304-3835(02)00025-3
Proteomics reveals protein profile changes in doxorubicin--treated MCF-7 human breast cancer cells.
S. Chen (2002)
10.1016/0006-2952(92)90443-M
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
C. Cuvier (1992)
10.1515/9783111419787-003
H
Yu-Qin Cao (1824)
10.1016/j.msec.2014.10.043
Applications of nanoparticles in treatment and diagnosis of leukemia.
Govind Soni (2015)
10.1021/am404680n
Multi-functional envelope-type nanoparticles assembled from amphiphilic peptidic prodrug with improved anti-tumor activity.
Jing-xiao Chen (2014)
10.1016/0006-2952(95)00226-P
Multidrug resistance bypass in cells exposed to doxorubicin-loaded nanospheres. Absence of endocytosis.
N. Henry-Toulmé (1995)
10.1016/j.jconrel.2016.02.016
Analyzing spatiotemporal distribution of uniquely fluorescent nanoparticles in xenograft tumors.
D. Stirland (2016)
10.1515/9783111576855-016
K
Martin P. Catherwood (1824)
10.1039/b712350g
Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics.
Hanene Ali-Boucetta (2008)
10.1016/j.ijpharm.2009.10.018
Polymer-based nanocapsules for drug delivery.
C. E. Mora-Huertas (2010)
10.1021/bm401471p
Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.
Y. Yu (2014)
10.1016/S0140-6736(05)61503-6
T
D. Davies (1998)
10.2147/IJN.S56506
Methotrexate diethyl ester-loaded lipid-core nanocapsules in aqueous solution increased antineoplastic effects in resistant breast cancer cell line
V. Yurgel (2014)
10.2147/IJN.S40284
The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways
A. Bernardi (2013)
10.1515/9783111697888-004
B
B. A. R. Kernfach (1824)
10.4172/2376-0419.S1.005
Drug nanocarriers as targeted therapies in cancer, the new chemotherapy
Edgar Pérez-Herrero (2015)
10.1016/j.addr.2013.11.009
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
N. Bertrand (2014)
10.1016/j.ejpb.2015.03.033
Design attributes of long-circulating polymeric drug delivery vehicles.
M. Beck-Broichsitter (2015)
10.1007/s00018-009-0053-z
Nanocarriers’ entry into the cell: relevance to drug delivery
H. Hillaireau (2009)
10.1016/j.ejps.2012.06.019
Nanoemulsion-templated multilayer nanocapsules for cyanine-type photosensitizer delivery to human breast carcinoma cells.
U. Bazylińska (2012)
Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.
F. Fornari (1994)
10.1515/9783111576855-015
J
Seguin Hen (1824)
10.1158/0008-5472.CAN-12-0777
Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.
Xiaoli Du (2012)
10.1021/am503974y
Zwitterionic nanoparticles constructed with well-defined reduction-responsive shell and pH-sensitive core for "spatiotemporally pinpointed" drug delivery.
P. Huang (2014)
10.1515/9783111697888-007
E
Adam S. Opalski (1824)
10.1515/9783111548050-034
W
Lohmarer Stadtgeschichte (2005)
10.1093/annonc/mdn661
Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531).
V. Roy (2009)
10.1109/TNB.2013.2274781
In Vitro and In Vivo Imaging of Peptide-Encapsulated Polymer Nanoparticles for Cancer Biomarker Activated Drug Delivery
Gulsim K. Kulsharova (2013)
10.1200/JCO.2005.11.013
Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer.
N. Ibrahim (2005)
10.5040/9781474284028.0024
S
A. Kumar (1824)
10.2147/IJN.S101543
Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models
C. Drewes (2016)
Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics
B. J. Berne (1976)
10.2307/j.ctvrnfqk1.10
? ? ? ? f ? ? ? ? ?
A. ADoefaa (2003)
10.1016/J.EJPS.2006.06.003
Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles.
D. Missirlis (2006)
10.1016/j.ejps.2009.04.008
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
Robhash Kusam Subedi (2009)
10.1166/JBN.2015.2125
Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model.
F. Figueiró (2015)
10.1016/j.ijpharm.2012.07.043
Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative.
L. Walker (2012)
10.1007/3-540-26367-5_1
A
A. Spring (2005)
10.1016/j.ejps.2015.07.018
Skin penetration behavior of lipid-core nanocapsules for simultaneous delivery of resveratrol and curcumin.
R. B. Friedrich (2015)
10.2147/IJN.S72590
In vitro cytotoxicity analysis of doxorubicin-loaded/superparamagnetic iron oxide colloidal nanoassemblies on MCF7 and NIH3T3 cell lines
K. Tománková (2015)
10.1515/9783111438443-006
N
Città DI Torino (1824)
10.2147/IJN.S46900
Nanopharmaceuticals (part 1): products on the market
V. Weissig (2014)
10.1152/ajpcell.00483.2010
Caveolae in cancer: two sides of the same coin? Focus on "Hydrogen peroxide inhibits non-small cell lung cancer cell anoikis through the inhibition of caveolin-1 degradation".
P. Lloyd (2011)
10.1016/J.JCONREL.2004.12.018
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
E. Lee (2005)
10.1016/B978-0-12-384931-1.00018-0
R
J. Lackie (2013)
10.1158/1538-7445.AM2012-4005
Abstract 4005: Active SHP2 mutant induces lung hyperproliferative lesions and adenoma in transgenic mice
V. Schneeberger (2012)
10.1166/JCSB.2012.1015
Fluorescent-Labeled Poly( ε -caprolactone) Lipid-Core Nanocapsules: Synthesis, Physicochemical Properties and Macrophage Uptake
Fernanda S. Poletto (2012)
10.1039/C2SM25754H
Lipid-core nanocapsules: mechanism of self-assembly, control of size and loading capacity
D. S. Jornada (2012)
10.1016/j.jconrel.2014.06.051
Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
Huixin Wang (2014)
Phase II trial of weekly nab ( nanoparticle albumin-bound )-paclitaxel ( nab-paclitaxel ) ( Abraxane ) in combination with gemcitabine in patients with metastatic breast cancer ( N 0531 )
V. Roy (2009)
10.1016/J.CHERD.2011.03.010
Preparation of polymer nanoparticles loaded with doxorubicin for controlled drug delivery
Federica Lince (2011)
10.1023/B:BREA.0000014042.54925.cc
Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update
M. Lacroix (2004)
10.1016/J.COLSURFA.2010.12.011
Formulation of lipid core nanocapsules
C. G. Venturini (2011)
10.1016/J.NANTOD.2011.02.003
Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies
T. Iversen (2011)



This paper is referenced by
Medicinal uses of Galenia africana: A study of the antimicrobial, antifungal and anticancer properties
T. Ng’uni (2017)
10.1016/B978-0-08-100716-7.00017-9
Polymeric and liposomal nanomaterials
C. Z. Bueno (2018)
10.1080/02652048.2019.1624849
Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins
R. Lorenzoni (2019)
10.1155/2017/1231464
Advances in Hybrid Polymer-Based Materials for Sustained Drug Release
Lígia N M Ribeiro (2017)
10.1016/j.ijpharm.2018.11.027
Biocompatibility studies of intravenously administered ionic‐crosslinked chitosan‐BSA nanoparticles as vehicles for antitumour drugs
N. Montero (2019)
10.1016/j.drudis.2018.05.040
Advances in treatment formulations for acute myeloid leukemia.
T. Briot (2018)
10.1016/j.nano.2019.102121
Encapsulation in lipid-core nanocapsules improves topical treatment with the potent antileishmanial compound CH8.
D. Escrivani (2019)
10.3390/nano8020075
An Inhalable Powder Formulation Based on Micro- and Nanoparticles Containing 5-Fluorouracil for the Treatment of Metastatic Melanoma
K. C. Zatta (2018)
10.1016/J.REACTFUNCTPOLYM.2018.09.018
Chemical stability, mass loss and hydrolysis mechanism of sterile and non-sterile lipid-core nanocapsules: The influence of the molar mass of the polymer wall
S. Calgaroto (2018)
10.3390/nano8010002
Arginylglycylaspartic Acid-Surface-Functionalized Doxorubicin-Loaded Lipid-Core Nanocapsules as a Strategy to Target Alpha(V) Beta(3) Integrin Expressed on Tumor Cells
M. B. Antonow (2017)
10.1007/s13204-020-01304-2
α-Lipoic acid nanocapsules fortified cow milk application as a dietary supplement product for anemia
Azeera Mohamed Saliq (2020)
10.1038/s41598-017-18573-7
Use of nanoparticle concentration as a tool to understand the structural properties of colloids
Lígia N M Ribeiro (2017)
10.1007/s11095-020-02804-0
Chitosan-Coated Lipid-Core Nanocapsules Functionalized with Gold-III and Bevacizumab Induced In Vitro Cytotoxicity against C6 Cell Line and In Vivo Potent Antiangiogenic Activity
Aline de Cristo Soares Alves (2020)
10.1016/j.ejpb.2019.01.001
Imiquimod‐loaded nanocapsules improve cytotoxicity in cervical cancer cell line
L. A. Frank (2019)
Semantic Scholar Logo Some data provided by SemanticScholar